{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:58:53Z","timestamp":1790125133299,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Guangxi","award":["2021GXNSFBA220073"],"award-info":[{"award-number":["2021GXNSFBA220073"]}]},{"name":"the third batch of Qi-huang Project high-level talent Team, Guangxi University of Traditional Chinese Medicine","award":["202411"],"award-info":[{"award-number":["202411"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160829"],"award-info":[{"award-number":["82160829"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98866-4","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T11:31:18Z","timestamp":1745839878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Integrated spatial and single cell transcriptomics identifies PRKDC as a dual prognostic biomarker and therapeutic target in hepatocellular carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Wenpeng","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuli","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"98866_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 74, 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"Cancer J. Clin."},{"key":"98866_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.semcancer.2023.04.010","volume":"93","author":"SA Polyzos","year":"2023","unstructured":"Polyzos, S. A., Chrysavgis, L., Vachliotis, I. D., Chartampilas, E. & Cholongitas, E. Nonalcoholic fatty liver disease and hepatocellular carcinoma:insights in epidemiology, pathogenesis, imaging, prevention and therapy. Sem. Cancer Biol. 93, 20\u201335. https:\/\/doi.org\/10.1016\/j.semcancer.2023.04.010 (2023).","journal-title":"Sem. Cancer Biol."},{"key":"98866_CR3","unstructured":"Asafo-Agyei, K. O. & Samant, H. Hepatocellular carcinoma. (StatPearls Publishing Copyright \u00a9 2025), StatPearls Publishing LLC., (2025)."},{"key":"98866_CR4","doi-asserted-by":"publisher","unstructured":"Wang, J. et al. Risk factors for hepatocellular carcinoma: an umbrella review of systematic review and meta-analysis. Ann. Med. 57 https:\/\/doi.org\/10.1080\/07853890.2025.2455539 (2025).","DOI":"10.1080\/07853890.2025.2455539"},{"key":"98866_CR5","doi-asserted-by":"publisher","unstructured":"Shen, K. Y., Zhu, Y., Xie, S. Z. & Qin, L. X. Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives. J. Hematol. Oncol. 17 https:\/\/doi.org\/10.1186\/s13045-024-01549-2 (2024).","DOI":"10.1186\/s13045-024-01549-2"},{"key":"98866_CR6","doi-asserted-by":"publisher","unstructured":"Singal, A. G. et al. Neoadjuvant and adjuvant systemic therapy in HCC: current status and the future. Hepatol. Commun. 8 https:\/\/doi.org\/10.1097\/hc9.0000000000000430 (2024).","DOI":"10.1097\/hc9.0000000000000430"},{"key":"98866_CR7","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1200\/jco.23.02745","volume":"42","author":"JD Gordan","year":"2024","unstructured":"Gordan, J. D. et al. Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline update. J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol. 42, 1830\u20131850. https:\/\/doi.org\/10.1200\/jco.23.02745 (2024).","journal-title":"J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol."},{"key":"98866_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1381612829666221216114350","volume":"29","author":"NU Butt","year":"2023","unstructured":"Butt, N. U. & Baytas, S. N. Advancements in hepatocellular carcinoma: potential preclinical drugs and their future. Curr. Pharm. Design. 29, 2\u201314. https:\/\/doi.org\/10.2174\/1381612829666221216114350 (2023).","journal-title":"Curr. Pharm. Design"},{"key":"98866_CR9","doi-asserted-by":"publisher","first-page":"108337","DOI":"10.1016\/j.compbiomed.2024.108337","volume":"173","author":"Z Bo","year":"2024","unstructured":"Bo, Z. et al. Application of artificial intelligence radiomics in the diagnosis, treatment, and prognosis of hepatocellular carcinoma. Comput. Biol. Med. 173, 108337. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108337 (2024).","journal-title":"Comput. Biol. Med."},{"key":"98866_CR10","doi-asserted-by":"publisher","unstructured":"Yin, Y. et al. Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside. Experimental Hematol. Oncol. 13 https:\/\/doi.org\/10.1186\/s40164-024-00539-x (2024).","DOI":"10.1186\/s40164-024-00539-x"},{"key":"98866_CR11","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3390\/cells9071665","volume":"9","author":"A Carusillo","year":"2020","unstructured":"Carusillo, A., Mussolino, C. D. N. A. & Damage From threat to treatment. Cells 9, 1665. https:\/\/doi.org\/10.3390\/cells9071665 (2020).","journal-title":"Cells"},{"key":"98866_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2015.2","volume":"16","author":"WP Roos","year":"2016","unstructured":"Roos, W. P., Thomas, A. D. & Kaina, B. DNA damage and the balance between survival and death in cancer biology. Nat. Rev. Cancer. 16, 20\u201333. https:\/\/doi.org\/10.1038\/nrc.2015.2 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"98866_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s13353-019-00516-9","volume":"60","author":"K Kiwerska","year":"2019","unstructured":"Kiwerska, K. & Szyfter, K. DNA repair in cancer initiation, progression, and therapy-a double-edged sword. J. Appl. Genet. 60, 329\u2013334. https:\/\/doi.org\/10.1007\/s13353-019-00516-9 (2019).","journal-title":"J. Appl. Genet."},{"key":"98866_CR14","doi-asserted-by":"publisher","first-page":"6798","DOI":"10.18632\/aging.204870","volume":"15","author":"HS Lin","year":"2023","unstructured":"Lin, H. S. et al. Molecular subtypes based on DNA sensors predict prognosis and tumor immunophenotype in hepatocellular carcinoma. Aging (Albany NY). 15, 6798\u20136821. https:\/\/doi.org\/10.18632\/aging.204870 (2023).","journal-title":"Aging (Albany NY)"},{"key":"98866_CR15","doi-asserted-by":"publisher","unstructured":"Soto-Palma, C., Niedernhofer, L. J., Faulk, C. D., Dong, X. & Epigenetics DNA damage, and aging. J. Clin. Invest. 132 https:\/\/doi.org\/10.1172\/jci158446 (2022).","DOI":"10.1172\/jci158446"},{"key":"98866_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.molcel.2007.11.015","volume":"28","author":"JW Harper","year":"2007","unstructured":"Harper, J. W. & Elledge, S. J. The DNA damage response: ten years after. Mol. Cell. 28, 739\u2013745. https:\/\/doi.org\/10.1016\/j.molcel.2007.11.015 (2007).","journal-title":"Mol. Cell"},{"key":"98866_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","volume":"40","author":"A Ciccia","year":"2010","unstructured":"Ciccia, A. & Elledge, S. J. The DNA damage response: making it safe to play with knives. Mol. Cell. 40, 179\u2013204. https:\/\/doi.org\/10.1016\/j.molcel.2010.09.019 (2010).","journal-title":"Mol. Cell"},{"key":"98866_CR18","doi-asserted-by":"publisher","first-page":"e1004563","DOI":"10.1371\/journal.pgen.1004563","volume":"10","author":"M Terasawa","year":"2014","unstructured":"Terasawa, M., Shinohara, A. & Shinohara, M. Canonical non-homologous end joining in mitosis induces genome instability and is suppressed by M-phase-specific phosphorylation of XRCC4. PLoS Genet. 10, e1004563. https:\/\/doi.org\/10.1371\/journal.pgen.1004563 (2014).","journal-title":"PLoS Genet."},{"key":"98866_CR19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/sj.embor.7400438","volume":"6","author":"LS Symington","year":"2005","unstructured":"Symington, L. S. Focus on recombinational DNA repair. EMBO Rep. 6, 512\u2013517. https:\/\/doi.org\/10.1038\/sj.embor.7400438 (2005).","journal-title":"EMBO Rep."},{"key":"98866_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-genet-110410-132435","volume":"45","author":"LS Symington","year":"2011","unstructured":"Symington, L. S. & Gautier, J. Double-strand break end resection and repair pathway choice. Annu. Rev. Genet. 45, 247\u2013271. https:\/\/doi.org\/10.1146\/annurev-genet-110410-132435 (2011).","journal-title":"Annu. Rev. Genet."},{"key":"98866_CR21","doi-asserted-by":"publisher","unstructured":"Sun, S. et al. Identification of PRKDC (Protein Kinase, DNA-Activated, Catalytic Polypeptide) as an essential gene for colorectal cancer (CRCs) cells. Gene 584, 90\u201396, (2016). https:\/\/doi.org\/10.1016\/j.gene.2016.03.020","DOI":"10.1016\/j.gene.2016.03.020"},{"key":"98866_CR22","doi-asserted-by":"publisher","first-page":"152509","DOI":"10.1016\/j.prp.2019.152509","volume":"215","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. PRKDC is a prognostic marker for poor survival in gastric cancer patients and regulates DNA damage response. Pathol. Res. Pract. 215, 152509. https:\/\/doi.org\/10.1016\/j.prp.2019.152509 (2019).","journal-title":"Pathol. Res. Pract."},{"key":"98866_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-024-01209-3","author":"J Xiong","year":"2024","unstructured":"Xiong, J. et al. Prognostic and potential therapeutic roles of PRKDC expression in lung Cancer. Mol. Biotechnol. https:\/\/doi.org\/10.1007\/s12033-024-01209-3 (2024).","journal-title":"Mol. Biotechnol."},{"key":"98866_CR24","doi-asserted-by":"publisher","unstructured":"Chen, Y. et al. Role of PRKDC in cancer initiation, progression, and treatment.  Cancer cell international 21, 563. https:\/\/doi.org\/10.1186\/s12935-021-02229-8 (2021).","DOI":"10.1186\/s12935-021-02229-8"},{"key":"98866_CR25","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1038\/oncsis.2012.14","volume":"1","author":"LE Moore","year":"2012","unstructured":"Moore, L. E. et al. Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation. Oncogenesis 1, e14. https:\/\/doi.org\/10.1038\/oncsis.2012.14 (2012).","journal-title":"Oncogenesis"},{"key":"98866_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13148-020-0822-y","volume":"12","author":"X Lu","year":"2020","unstructured":"Lu, X. et al. Epigenetic age acceleration of cervical squamous cell carcinoma converged to human papillomavirus 16\/18 expression, immunoactivation, and favourable prognosis. Clin. Epigenetics. 12, 23. https:\/\/doi.org\/10.1186\/s13148-020-0822-y (2020).","journal-title":"Clin. Epigenetics"},{"key":"98866_CR27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s12029-017-9959-0","volume":"48","author":"A Ozakyol","year":"2017","unstructured":"Ozakyol, A. Global epidemiology of hepatocellular carcinoma (HCC epidemiology). J. Gastrointest. cancer. 48, 238\u2013240 (2017).","journal-title":"J. Gastrointest. cancer"},{"issue":"Suppl 1","key":"98866_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/liv.14865","volume":"41","author":"R Sartoris","year":"2021","unstructured":"Sartoris, R., Gregory, J., Dioguardi Burgio, M., Ronot, M. & Vilgrain, V. HCC advances in diagnosis and prognosis: digital and imaging. Liver International: Official J. Int. Association Study Liver. 41(Suppl 1), 73\u201377. https:\/\/doi.org\/10.1111\/liv.14865 (2021).","journal-title":"Liver International: Official J. Int. Association Study Liver"},{"key":"98866_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s12253-019-00585-5","volume":"26","author":"P Luo","year":"2020","unstructured":"Luo, P. et al. Current status and perspective biomarkers in AFP negative HCC: towards screening for and diagnosing hepatocellular carcinoma at an earlier stage. Pathol. Oncol. Research: POR. 26, 599\u2013603. https:\/\/doi.org\/10.1007\/s12253-019-00585-5 (2020).","journal-title":"Pathol. Oncol. Research: POR"},{"key":"98866_CR30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41416-019-0513-7","volume":"121","author":"R Montal","year":"2019","unstructured":"Montal, R. et al. Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials. Br. J. Cancer. 121, 340\u2013343. https:\/\/doi.org\/10.1038\/s41416-019-0513-7 (2019).","journal-title":"Br. J. Cancer"},{"key":"98866_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3350\/cmh.2022.0212","volume":"29","author":"DY Kim","year":"2023","unstructured":"Kim, D. Y. et al. Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region. Clin. Mol. Hepatol. 29, 277\u2013292. https:\/\/doi.org\/10.3350\/cmh.2022.0212 (2023).","journal-title":"Clin. Mol. Hepatol."},{"key":"98866_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejrad.2018.01.025","volume":"101","author":"C Ayuso","year":"2018","unstructured":"Ayuso, C. et al. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. Eur. J. Radiol. 101, 72\u201381. https:\/\/doi.org\/10.1016\/j.ejrad.2018.01.025 (2018).","journal-title":"Eur. J. Radiol."},{"key":"98866_CR33","doi-asserted-by":"publisher","first-page":"e29628","DOI":"10.1097\/md.0000000000029628","volume":"101","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. Potential value of PRKDC as a therapeutic target and prognostic biomarker in pan-cancer. Medicine 101, e29628. https:\/\/doi.org\/10.1097\/md.0000000000029628 (2022).","journal-title":"Medicine"},{"key":"98866_CR34","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1158\/1078-0432.Ccr-14-0842","volume":"21","author":"L Cornell","year":"2015","unstructured":"Cornell, L. et al. DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival. Clin. cancer Research: Official J. Am. Association Cancer Res. 21, 925\u2013933. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-14-0842 (2015).","journal-title":"Clin. cancer Research: Official J. Am. Association Cancer Res."},{"key":"98866_CR35","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.18632\/aging.205855","volume":"16","author":"Y Pan","year":"2024","unstructured":"Pan, Y., Zhu, Q., Hong, T., Cheng, J. & Tang, X. Targeting PRKDC activates the efficacy of antitumor immunity while sensitizing to chemotherapy and targeted therapy in liver hepatocellular carcinoma. Aging 16, 9047\u20139071. https:\/\/doi.org\/10.18632\/aging.205855 (2024).","journal-title":"Aging"},{"key":"98866_CR36","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1038\/s41467-021-24010-1","volume":"12","author":"DW Ho","year":"2021","unstructured":"Ho, D. W. et al. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma. Nat. Commun. 12, 3684. https:\/\/doi.org\/10.1038\/s41467-021-24010-1 (2021).","journal-title":"Nat. Commun."},{"key":"98866_CR37","doi-asserted-by":"publisher","first-page":"596318","DOI":"10.3389\/fonc.2020.596318","volume":"10","author":"S Zhang","year":"2020","unstructured":"Zhang, S. et al. -Seq analysis reveals microenvironmental infiltration of plasma cells and hepatocytic prognostic markers in HCC with cirrhosis. Front. Oncol. 10, 596318. https:\/\/doi.org\/10.3389\/fonc.2020.596318 (2020).","journal-title":"Front. Oncol."},{"key":"98866_CR38","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.7150\/thno.71873","volume":"12","author":"YF Wang","year":"2022","unstructured":"Wang, Y. F. et al. Spatial maps of hepatocellular carcinoma transcriptomes reveal Spatial expression patterns in tumor immune microenvironment. Theranostics 12, 4163\u20134180. https:\/\/doi.org\/10.7150\/thno.71873 (2022).","journal-title":"Theranostics"},{"key":"98866_CR39","doi-asserted-by":"publisher","first-page":"0387","DOI":"10.34133\/research.0387","volume":"7","author":"J Ye","year":"2024","unstructured":"Ye, J. et al. Integrating Single-Cell and Spatial transcriptomics to uncover and elucidate GP73-Mediated Pro-Angiogenic regulatory networks in hepatocellular carcinoma. Res. (Washington D C). 7, 0387. https:\/\/doi.org\/10.34133\/research.0387 (2024).","journal-title":"Res. (Washington D C)"},{"key":"98866_CR40","doi-asserted-by":"publisher","unstructured":"Tellez-Gabriel, M., Ory, B., Lamoureux, F., Heymann, M. F. & Heymann, D. Tumour heterogeneity: the key advantages of Single-Cell analysis. Int. J. Mol. Sci. 17 https:\/\/doi.org\/10.3390\/ijms17122142 (2016).","DOI":"10.3390\/ijms17122142"},{"key":"98866_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-024-02062-3","volume":"23","author":"DZ Guo","year":"2024","unstructured":"Guo, D. Z. et al. Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts. Mol. Cancer. 23, 157. https:\/\/doi.org\/10.1186\/s12943-024-02062-3 (2024).","journal-title":"Mol. Cancer"},{"key":"98866_CR42","doi-asserted-by":"publisher","unstructured":"Zhao, N. et al. Spatial maps of hepatocellular carcinoma transcriptomes highlight an unexplored landscape of heterogeneity and a novel gene signature for survival. Cancer Cell Int. 22 https:\/\/doi.org\/10.1186\/s12935-021-02430-9 (2022).","DOI":"10.1186\/s12935-021-02430-9"},{"key":"98866_CR43","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1177\/0300891620950472","volume":"107","author":"Y Yin","year":"2021","unstructured":"Yin, Y. et al. Emerging functions of PRKDC in the initiation and progression of cancer. Tumori 107, 483\u2013488. https:\/\/doi.org\/10.1177\/0300891620950472 (2021).","journal-title":"Tumori"},{"key":"98866_CR44","doi-asserted-by":"publisher","first-page":"e908","DOI":"10.1002\/mgg3.908","volume":"7","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. High expression of PRKDC promotes breast cancer cell growth via p38 MAPK signaling and is associated with poor survival. Mol. Genet. Genom. Med. 7, e908. https:\/\/doi.org\/10.1002\/mgg3.908 (2019).","journal-title":"Mol. Genet. Genom. Med."},{"key":"98866_CR45","doi-asserted-by":"publisher","first-page":"591739","DOI":"10.3389\/fonc.2020.591739","volume":"10","author":"XB Ma","year":"2020","unstructured":"Ma, X. B., Xu, Y. Y., Zhu, M. X. & Wang, L. Prognostic signatures based on thirteen Immune-Related genes in colorectal Cancer. Front. Oncol. 10, 591739. https:\/\/doi.org\/10.3389\/fonc.2020.591739 (2020).","journal-title":"Front. Oncol."},{"key":"98866_CR46","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bj.2021.02.003","volume":"44","author":"O P\u00f6s","year":"2021","unstructured":"P\u00f6s, O. et al. DNA copy number variation: main characteristics, evolutionary significance, and pathological aspects. Biomedical J. 44, 548\u2013559. https:\/\/doi.org\/10.1016\/j.bj.2021.02.003 (2021).","journal-title":"Biomedical J."},{"key":"98866_CR47","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.2217\/epi-2022-0287","volume":"14","author":"L van der Laan","year":"2022","unstructured":"van der Laan, L. et al. DNA methylation episignatures: insight into copy number variation. Epigenomics 14, 1373\u20131388. https:\/\/doi.org\/10.2217\/epi-2022-0287 (2022).","journal-title":"Epigenomics"},{"key":"98866_CR48","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1053\/j.gastro.2015.05.061","volume":"149","author":"J Zucman-Rossi","year":"2015","unstructured":"Zucman-Rossi, J., Villanueva, A., Nault, J. C. & Llovet, J. M. Genetic landscape and biomarkers of hepatocellular carcinoma. Gastroenterology 149, 1226\u20131239e1224. https:\/\/doi.org\/10.1053\/j.gastro.2015.05.061 (2015).","journal-title":"Gastroenterology"},{"key":"98866_CR49","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/tox.24062","volume":"39","author":"J Zheng","year":"2024","unstructured":"Zheng, J., Chen, J., Wang, S., Yang, D. & Zhou, P. Genomic and immune landscape in hepatocellular carcinoma: implications for personalized therapeutics. Environ. Toxicol. 39, 1601\u20131616. https:\/\/doi.org\/10.1002\/tox.24062 (2024).","journal-title":"Environ. Toxicol."},{"key":"98866_CR50","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/hep.31659","volume":"74","author":"G Hernandez-Meza","year":"2021","unstructured":"Hernandez-Meza, G. et al. DNA methylation profiling of human hepatocarcinogenesis. Hepatol. (Baltimore Md). 74, 183\u2013199. https:\/\/doi.org\/10.1002\/hep.31659 (2021).","journal-title":"Hepatol. (Baltimore Md)"},{"key":"98866_CR51","doi-asserted-by":"crossref","unstructured":"Hung, M. H. & Wang, X. W. Molecular alterations and heterogeneity in hepatocellular carcinoma.  293\u2013316 (Humana Press Copyright 2019, Springer Nature Switzerland AG., 2019).","DOI":"10.1007\/978-3-030-21540-8_14"},{"key":"98866_CR52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","volume":"16","author":"JS O\u2019Donnell","year":"2019","unstructured":"O\u2019Donnell, J. S., Teng, M. W. L. & Smyth, M. J. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat. Rev. Clin. Oncol. 16, 151\u2013167. https:\/\/doi.org\/10.1038\/s41571-018-0142-8 (2019).","journal-title":"Nat. Rev. Clin. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98866-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98866-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98866-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T11:31:22Z","timestamp":1745839882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98866-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98866"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98866-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14834"}}